Original Research
Published on 03 Dec 2020
Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?
in Addictive Disorders
Frontiers in Psychiatry
doi 10.3389/fpsyt.2020.598150
- 21,595 views
- 11 citations



